Segall Bryant & Hamill, LLC Haemonetics Corp Transaction History
Segall Bryant & Hamill, LLC
- $6.35 Billion
- Q1 2025
A detailed history of Segall Bryant & Hamill, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 21,410 shares of HAE stock, worth $1.35 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
21,410Holding current value
$1.35 Million% of portfolio
0.02%Shares
14 transactions
Others Institutions Holding HAE
# of Institutions
344Shares Held
52.4MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$376 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$326 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$279 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$267 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.55MShares$161 Million0.12% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.23B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...